Detalhe da pesquisa
1.
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK.
Support Care Cancer
; 32(3): 199, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421441
2.
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
Br J Cancer
; 128(4): 549-555, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434154
3.
Where Are We Now with Liver Transplantation in Neuroendocrine Neoplasms? The Place of Liver Transplantation for Grades 1 and 2 Well-Differentiated Unresectable Liver Metastatic Neuroendocrine Tumours.
Curr Oncol Rep
; 25(2): 135-144, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648705
4.
Plasma or serum 5-hydroxyindoleacetic acid can be used interchangeably in patients with neuroendocrine tumours.
Scand J Clin Lab Invest
; 83(8): 576-581, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112030
5.
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
Neuroendocrinology
; 112(3): 298-310, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940581
6.
What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
Curr Oncol Rep
; 24(10): 1281-1286, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35554845
7.
177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1752-1763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793718
8.
177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life.
Eur J Nucl Med Mol Imaging
; 48(11): 3582-3594, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33835221
9.
Home Total Parenteral Nutrition for Intestinal Failure in Patients with Advanced Small Intestinal Neuroendocrine Neoplasms.
Nutr Cancer
; 73(9): 1638-1643, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865033
10.
Antiproliferative Effect of Above-Label Doses of Somatostatin Analogs for the Management of Gastroenteropancreatic Neuroendocrine Tumors.
Neuroendocrinology
; 111(7): 650-659, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541155
11.
Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications.
Neuroendocrinology
; 111(10): 907-924, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717739
12.
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients.
Neuroendocrinology
; 111(9): 863-875, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950978
13.
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study.
EJC Suppl
; 16: 14-23, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912479
14.
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.
Lancet Oncol
; 21(9): e431-e443, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888472
15.
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Int J Cancer
; 146(5): 1316-1323, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31509608
16.
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
N Engl J Med
; 376(2): 125-135, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076709
17.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Eur J Nucl Med Mol Imaging
; 47(10): 2372-2382, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123969
18.
Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors.
Anticancer Drugs
; 31(3): 216-222, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977567
19.
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Br J Cancer
; 120(3): 294-300, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636773
20.
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.
Oncologist
; 24(8): e662-e670, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651397